Showing results (781-790 of 30,232) with videos related to
Sort By:
Pageof 3,024
Frontiers in Pharmacology|July 25, 2022
The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic TargetYinghong Wang, Xiaojie Hu, Yancai Sun, et al.Frontiers in Pharmacology|July 25, 2022
Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer ActivityKirill Kirsanov, Timur Fetisov, Elena Antoshina, et al.Frontiers in Pharmacology|July 25, 2022
Potential Anti-Depressive Effects and Mechanisms of Zhi-Zi Hou-Po Decoction Using Behavioral Despair Tests Combined With in Vitro ApproachesYongtao Bai, Guoliang Dai, Lihua Song, et al.Frontiers in Pharmacology|July 18, 2022
Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver FibrosisXiao-Feng Chen, Yumei Wang, Shaoxiu Ji, et al.Frontiers in Pharmacology|July 18, 2022
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative ReviewMd Sanower Hossain, Md Abdul Kader, Khang Wen Goh, et al.Frontiers in Pharmacology|July 18, 2022
Icariside Ⅱ Attenuates Palmitic Acid-Induced Endothelial Dysfunction Through SRPK1-Akt-eNOS Signaling PathwayYang-Yang Gu, Xiao-Hui Tan, Wen-Peng Song, et al.Frontiers in Pharmacology|July 18, 2022
Characterization of ADME Gene Variation in Colombian Population by Exome SequencingDaniel Felipe Silgado-Guzmán, Mariana Angulo-Aguado, Adrien Morel, et al.Frontiers in Pharmacology|July 18, 2022
Relation Between Gender and Concomitant Medications With Erythropoietin-Treatment on Wound Healing in Burn Patients. Post Hoc Subgroup-Analysis of the Randomized, Placebo-Controlled Clinical Trial "EPO in Burns"Christina Irene Günter, Felicitas Paula Ilg, Alexander Hapfelmeier, et al.Frontiers in Pharmacology|July 18, 2022
Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and AutophagyXujun You, Yongrong Wu, Qixin Li, et al.Frontiers in Pharmacology|July 18, 2022
Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary TherapyJiaoli Wang, Haoran Hu, Haixia Du, et al.Pageof 3,024